Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 2195-2205, December 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bates, H. M.
Right arrow Articles by Watson, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bates, H. M.
Right arrow Articles by Watson, W. B.

Studies on the Mechanism of Action of Anthramycin Methyl Ether, A New Antitumor Antibiotic

H. M. Bates1, W. Kuenzig and W. B. Watson

Department of Pharmacology, Research Division, Hoffmann-LaRoche, Inc., Nutley, New Jersey 07110

Anthramycin methyl ether (AME), an antibiotic with antitumor activity, inhibits the in vivo and in vitro synthesis of RNA and DNA by Ehrlich ascites carcinoma cells. AME is a competitive inhibitor (with respect to DNA) of the cell-free synthesis of RNA and DNA by the DNA-dependent polymerase enzymes, as well as the enzymatic hydrolysis of DNA by DNase I. The interaction of AME with DNA was demonstrated by the isolation of an AME-DNA complex by gel filtration chromatography on Sephadex G-50 columns, by equilibrium dialysis studies, by ultraviolet absorption spectroscopy, by an increase in the melting temperature (Tm) of DNA when AME was added, and by the displacement of methyl green from a DNA-methyl green complex by AME. The DNA helix must be intact for AME to bind to DNA and for AME to inhibit the DNA-dependent enzymic reactions.

These results are compatible with the proposition that AME exerts its actions as a growth inhibitor by interacting with helical, double-stranded DNA to form an AME-DNA complex, which in turn prevents DNA from participating as a template in the biosynthesis of RNA and DNA.

1 Present address: Wallace Laboratories, Division of Carter-Wallace, Inc., Cranbury, New Jersey 08512.

Received 10/10/68. Accepted 4/24/69.




This article has been cited by other articles:


Home page
ScienceHome page
S. B. Horwitz, S. C. Chang, A. P. Grollman, and A. B. Borcaronkovec
Chemosterilant Action of Anthramycin: A Proposed Mechanism
Science, October 8, 1971; 174(4005): 159 - 161.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.